Literature DB >> 19705060

What can be learned from the history of recurrence in migraine? A comment.

Peer Tfelt-Hansen1.   

Abstract

Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatriptan. The history of recurrence in early sumatriptan randomised clinical trials is described. Recurrence has been ascribed to patient-dependent factors but experience with ergot alkaloids suggested that recurrence can also be treatment-dependent. Possible mechanisms for recurrence are discussed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19705060      PMCID： PMC3452092          DOI： 10.1007/s10194-009-0144-0

Source DB:  PubMed          Journal:  J Headache Pain        ISSN： 1129-2369            Impact factor:   7.277


  41 in total

1.  Frovatriptan and data publication.

Authors:  Peer Tfelt-Hansen
Journal:  Headache       Date:  2008-10       Impact factor: 5.887

Review 2.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

4.  Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Authors:  M D Ferrari; P J Goadsby; K I Roon; R B Lipton
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

5.  What do patients with migraine want from acute migraine treatment?

Authors:  Richard B Lipton; Sandra W Hamelsky; Jeffrey M Dayno
Journal:  Headache       Date:  2002-01       Impact factor: 5.887

6.  Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.

Authors:  P Tfelt-Hansen; J Teall; F Rodriguez; M Giacovazzo; J Paz; W Malbecq; G A Block; S A Reines; W H Visser
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

7.  In vitro studies on the duration of action of dihydroergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980

8.  Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery.

Authors:  J R Ostergaard; E Mikkelsen; B Voldby
Journal:  Cephalalgia       Date:  1981-12       Impact factor: 6.292

9.  Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case.

Authors:  P Tfelt-Hansen; J R Ostergaard; I Gøthgen; E Jacobsen; J P Rasmussen; B Husum
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 10.  Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.

Authors:  Gilles Géraud; Charlotte Keywood; Jean Michel Senard
Journal:  Headache       Date:  2003-04       Impact factor: 5.887
View more
  1 in total

1.  Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.

Authors:  Benjamin W Friedman; Clemencia Solorzano; David Esses; Shujun Xia; Michael Hochberg; Niels Dua; Alan Heins; Paul Sasso; Polly E Bijur; Richard B Lipton; E John Gallagher
Journal:  Ann Emerg Med       Date:  2010-03-19       Impact factor: 5.721
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.